1
|
Wang L, Liu T, Guo J, Zhao T, Tang H, Wang F, Dong F, Chen J, Tang M. N-3 PUFA supplementation alleviates anxiety symptoms by manipulating erythrocyte fatty acid levels in depression. Eur J Nutr 2024; 63:2271-2279. [PMID: 38758363 DOI: 10.1007/s00394-024-03421-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Accepted: 04/29/2024] [Indexed: 05/18/2024]
Abstract
PURPOSE Major depressive disorder (MDD) is frequently accompanied by the symptoms of clinical anxiety. Since our previous research has found that n-3 PUFA supplementation alleviates anxiety in MDD, this study was aimed to further explore whether n-3 PUFA supplementation improves anxiety symptoms in depression by directly manipulating fatty acid levels. METHODS A secondary analysis of biomarker data (erythrocyte fatty acid composition) collected as part of the randomized clinical trial which investigated the adjunctive effect of n-3 PUFAs was conducted on 72 venlafaxine-treated outpatients with first-diagnosed, drug-naïve depression. All participants with longitudinal biomarker data were included in the association analysis to determine how n-3 PUFA supplementation influences fatty acid composition and alleviates anxiety symptoms in depression. RESULTS Decreases of the C20:3n6 were found in all participants at both follow-up time points (χ2 = 96.36, p = 0.000). The n-3 index (χ2 = 10.59, p = 0.001), EPA (χ2 = 24.31, p = 0.000), and C22:5n3/C20:5n3 ratio (χ2 = 10.71, p = 0.001) were increased, while C22:4n6 (χ2 = 7.703, p = 0.006) was decreased in n-3 PUFA group compared to the placebo group. The improvement in anxiety symptoms positively correlates with the extent of reduction of C16:0, C18:0, and total fatty acid levels as well as D5 desaturase activity (p < 0.05). CONCLUSION These data suggest that the anxiolytic effect exerted by n-3 PUFAs in first-diagnosed, drug-naïve depression is manipulated by erythrocyte fatty acid levels. Saturated fatty acid levels have an important role in predicting the severity of anxiety symptoms.
Collapse
Affiliation(s)
- Lu Wang
- The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders and Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China
- Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, and China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China
| | - Ting Liu
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China
| | - Jimin Guo
- College of Materials Sciences and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China
| | - Tingyu Zhao
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China
| | - Hui Tang
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, and China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China
| | - Feifei Wang
- The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders and Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China
- Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, and China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China
| | - Fang Dong
- The National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders and Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China
- Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, and China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China
| | - Jindong Chen
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, and China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China
| | - Mimi Tang
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
| |
Collapse
|
2
|
Gora AH, Rehman S, Dias J, Fernandes JMO, Olsvik PA, Sørensen M, Kiron V. Microbial oil, alone or paired with β-glucans, can control hypercholesterolemia in a zebrafish model. Biochim Biophys Acta Mol Cell Biol Lipids 2023; 1868:159383. [PMID: 37657755 DOI: 10.1016/j.bbalip.2023.159383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 07/12/2023] [Accepted: 08/29/2023] [Indexed: 09/03/2023]
Abstract
Dyslipidemia is often associated with unhealthy dietary habits, and many mammalian studies have explored the mode of action of certain bioactive compounds such as β-glucans and n-3 PUFAs to understand their potential to normalize the lipid metabolism. There are only a few investigations that adopted omic approaches to unveil their combined effect on hypercholesterolemia. Zebrafish (Danio rerio) was used as a model organism to reveal the efficacy of Schizochytrium oil and β-glucans (from Euglena gracilis and Phaeodactylum tricornutum) against cholesterol-rich diet induced dyslipidemia. One of the folowing four diets was fed to a particular group of fish: a control high-cholesterol diet, a Schizochytrium oil diet or one of the two diets containing the oil and β-glucan. The plasma HDL, expression of hepatic genes linked to, among others, ferric ion binding and plasma phosphatidylcholines were higher and plasma cholesterol esters and triacylglycerols were lower in the microbial oil-fed fish compared to the fish fed high cholesterol diet. While the fish fed a mix of microbial oil and Euglena β-glucan had lower plasma triacylglycerols and expression of hepatic genes linked to PPAR signaling pathway and enriched biosynthesis of plasma unsaturated fatty acids, the fish fed microbial oil-Phaeodactylum β-glucan combination had lower abundance of triacylglycerols rich in saturated and mono-unsaturated fatty acids and cholesterol esters in the plasma.
Collapse
Affiliation(s)
- Adnan H Gora
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | - Saima Rehman
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | | | | | - Pål A Olsvik
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | - Mette Sørensen
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | - Viswanath Kiron
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
| |
Collapse
|
3
|
Tejero Pérez A, Kapravelou G, Porres Foulquie JM, López Jurado Romero de la Cruz M, Martínez Martínez R. Potential benefits of microalgae intake against metabolic diseases: beyond spirulina-a systematic review of animal studies. Nutr Rev 2023:nuad098. [PMID: 37643736 DOI: 10.1093/nutrit/nuad098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/31/2023] Open
Abstract
CONTEXT Microalgae are a diverse source of bioactive molecules, such as polyphenols, carotenoids, and omega-3 fatty acids, with beneficial properties in biomarkers of metabolic diseases. Unlike the rest of the microalgae genera, Arthrospira sp., commonly called spirulina, has been widely studied. OBJECTIVE This review aims to describe the current knowledge about microalgae, besides spirulina, focusing on their beneficial properties against metabolic diseases. DATA SOURCES A systematic research of MEDLINE (via PubMed), Cochrane, and Scopus databases was conducted to identify relevant studies published after January 2012. In vivo animal studies including microalgae consumption, except for spirulina, that significantly improved altered biomarkers related to metabolic diseases were included. These biomarkers included body weight/composition, glucose metabolism, lipid metabolism, oxidative damage, inflammation markers, and gut microbiota. DATA EXTRACTION After the literature search and the implementation of inclusion and exclusion criteria, 37 studies were included in the revision out of the 132 results originally obtained after the application of the equation on the different databases. DATA ANALYSIS Data containing 15 microalgae genera were included reporting on a wide range of beneficial results at different levels, including a decrease in body weight and changes in plasma levels of glucose and lipoproteins due to molecular alterations such as those related to gene expression regulation. The most reported beneficial effects were related to gut microbiota and inflammation followed by lipid and glucose metabolism and body weight/composition. CONCLUSIONS Microalgae intake improved different altered biomarkers due to metabolic diseases and seem to have potential in the design of enriched foodstuffs or novel nutraceuticals. Nevertheless, to advance to clinical trials, more thorough/detailed studies should be performed on some of the microalgae genera included in this review to collect more information on their molecular mechanisms of action.
Collapse
Affiliation(s)
- Adrian Tejero Pérez
- Faculty of Chemical Sciences and Technologies, Universidad de Castilla-La Mancha, Ciudad Real, Spain
- Faculty of Medicine, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Ciudad Real, Spain
- Department of Physiology, Biomedical Research Center (CIBM), Instituto Mixto Universitario Deporte y Salud (IMUDS), Universidad de Granada, Granada, Spain
| | - Garyfallia Kapravelou
- Department of Physiology, Biomedical Research Center (CIBM), Instituto Mixto Universitario Deporte y Salud (IMUDS), Universidad de Granada, Granada, Spain
| | - Jesús María Porres Foulquie
- Department of Physiology, Biomedical Research Center (CIBM), Instituto Mixto Universitario Deporte y Salud (IMUDS), Universidad de Granada, Granada, Spain
| | - María López Jurado Romero de la Cruz
- Department of Physiology, Biomedical Research Center (CIBM), Instituto Mixto Universitario Deporte y Salud (IMUDS), Universidad de Granada, Granada, Spain
| | - Rosario Martínez Martínez
- Department of Physiology, Biomedical Research Center (CIBM), Instituto Mixto Universitario Deporte y Salud (IMUDS), Universidad de Granada, Granada, Spain
| |
Collapse
|
4
|
Gora AH, Rehman S, Dias J, Fernandes JMO, Olsvik PA, Sørensen M, Kiron V. Protective mechanisms of a microbial oil against hypercholesterolemia: evidence from a zebrafish model. Front Nutr 2023; 10:1161119. [PMID: 37435570 PMCID: PMC10332275 DOI: 10.3389/fnut.2023.1161119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 04/20/2023] [Indexed: 07/13/2023] Open
Abstract
A Western diet elevates the circulating lipoprotein and triglyceride levels which are the major risk factors in cardiovascular disease (CVD) development. Consumption of long-chain omega-3 fatty acids can stall the disease progression. Although these fatty acids can significantly impact the intestine under a hypercholesterolemic condition, the associated changes have not been studied in detail. Therefore, we investigated the alterations in the intestinal transcriptome along with the deviations in the plasma lipids and liver histomorphology of zebrafish offered DHA- and EPA-rich oil. Fish were allocated to 4 dietary treatments: a control group, a high cholesterol group and microbial oil groups with low (3.3%) and high (6.6%) inclusion levels. We quantified the total cholesterol, lipoprotein and triglyceride levels in the plasma. In addition, we assessed the liver histology, intestinal transcriptome and plasma lipidomic profiles of the study groups. The results suggested that higher levels of dietary microbial oil could control the CVD risk factor indices in zebrafish plasma. Furthermore, microbial oil-fed fish had fewer liver vacuoles and higher mRNA levels of genes involved in β-oxidation and HDL maturation. Analyses of the intestine transcriptome revealed that microbial oil supplementation could influence the expression of genes altered by a hypercholesterolemic diet. The plasma lipidomic profiles revealed that the higher level of microbial oil tested could elevate the long-chain poly-unsaturated fatty acid content of triglyceride species and lower the concentration of several lysophosphatidylcholine and diacylglycerol molecules. Our study provides insights into the effectiveness of microbial oil against dyslipidemia in zebrafish.
Collapse
Affiliation(s)
- Adnan H. Gora
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | - Saima Rehman
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | | | | | - Pål A. Olsvik
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | - Mette Sørensen
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| | - Viswanath Kiron
- Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway
| |
Collapse
|
5
|
Ran L, Yu J, Ma R, Yao Q, Wang M, Bi Y, Yu Z, Wu Y. Microalgae oil from Schizochytrium sp. alleviates obesity and modulates gut microbiota in high-fat diet-fed mice. Food Funct 2022; 13:12799-12813. [PMID: 36421064 DOI: 10.1039/d2fo01772e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Omega-3 PUFAs rich in fish oil are believed to prevent obesity by improving lipid metabolism and regulating gut microbiota. Microalgae oil is considered as an alternative source of omega-3 PUFAs owing to diminishing fish resources. Schizochytrium microalgae oil (SMO), with a high DHA proportion, is a promising source for commercial DHA production. However, its weight-loss and gut microbiota-regulating properties are not well studied. Here we compared the obesity reducing effects of SMO, commercial fish oil (FO) and a weight-loss drug, Orlistat (OL), in a high-fat diet (HFD) induced obesity mouse model. We found that SMO is comparable to commercial FO and OL with regard to weight loss, and it even exhibits the weight-loss effects earlier than FO and OL. It can efficiently inhibit the expression of lipogenesis-related genes and induce the expression of lipolysis-related genes. Moreover, SMO has different gut microbiota modulating effects from those of FO and OL. It does not influence the diversity of bacterial community, but does increase the abundance of several beneficial SCFAs-producing bacteria and inhibits obesity-promoting Desulfovibrio and several pathogens. We also found that SMO recovers the HFD-disturbed metabolic capability of gut microbiota. It can increase the abundance of several metabolism-related pathways, such as those of amino acids, SCFAs and bile acid, and decrease the level of the LPS biosynthesis pathway, which probably contributes to an improvement of lipid metabolism and restoration of the colonic mucosal barrier impaired by HFD. Our data suggest that SMO can be used as a superior dietary supplement for alleviating obesity.
Collapse
Affiliation(s)
- Liyuan Ran
- College of Laboratory Animals (Shandong Laboratory Animal Center), Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
| | - Jinhui Yu
- Institute of Genome Engineered Animal Models for Human Diseases, Dalian Medical University, Dalian, 116044, China.,National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, Dalian, 116044, China.,Institute of Crop Germplasm Resources, Shandong Academy of Agricultural Sciences, Jinan, 250100, China
| | - Rui Ma
- Institute of Genome Engineered Animal Models for Human Diseases, Dalian Medical University, Dalian, 116044, China.,National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, Dalian, 116044, China
| | - Qing Yao
- Institute of Genome Engineered Animal Models for Human Diseases, Dalian Medical University, Dalian, 116044, China.,National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, Dalian, 116044, China
| | - Mingjie Wang
- Shandong Provincial Hospital, Shandong University, Jinan, China.,Department of Endocrinology, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia Medical University, Inner Mongolia, China
| | - Yuping Bi
- Institute of Crop Germplasm Resources, Shandong Academy of Agricultural Sciences, Jinan, 250100, China
| | - Zichao Yu
- College of Laboratory Animals (Shandong Laboratory Animal Center), Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
| | - Yingjie Wu
- College of Laboratory Animals (Shandong Laboratory Animal Center), Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China. .,Institute of Genome Engineered Animal Models for Human Diseases, Dalian Medical University, Dalian, 116044, China.,National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, Dalian, 116044, China
| |
Collapse
|
6
|
Dineshbabu G, Goswami G, Kumar R, Sinha A, Das D. Microalgae–nutritious, sustainable aqua- and animal feed source. J Funct Foods 2019. [DOI: 10.1016/j.jff.2019.103545] [Citation(s) in RCA: 54] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
|
7
|
Tang M, Floyd S, Cai H, Zhang M, Yang R, Dang R. The status of ω-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway. Food Funct 2019; 10:4649-4660. [PMID: 31292598 DOI: 10.1039/c9fo00076c] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Metabolic disturbances, including lipid metabolism, bone metabolism, and glycometabolism, are common in depression. Omega-3 polyunsaturated fatty acids (ω-3 PUFAs), which are reported to possess antidepressant effect, have also been shown to regulate metabolism. To further clarify the potential link between ω-3 PUFAs and stress-induced metabolic disturbances, metabolic-related parameters including body weight, visceral fat, fatty acid composition and serum parameters, such as serum lipids, free fatty acid (FFA), glucose (GLU), calcium and phosphorus in rats were measured. Moreover, hepatic insulin induced gene (INSIG)/sterol regulatory element binding protein (SREBP) pathway was also investigated. After 5 weeks of chronic unpredicted mild stress (CUMS) administration, rats were induced to a depressive-like state and exhibited decreased serum high-density lipoprotein (HDL-c), body weight and visceral fat, accompanied by altered C18:2n6c and ω-3/ω-6 PUFAs. Supplement of ω-3 PUFAs showed robust antidepressant effects and has beneficial effects on lipid profile. On the contrary, ω-3 PUFAs deficiency induced the visceral fat accumulation and decreased the serum calcium and phosphorus in stressed rats. Additionally, CUMS significantly increased hepatic expressions of SREBP-cleavage activating protein (SCAP)/SREBP-1 and decreased the expression of INSIG-1. This disturbance of SREBPs system is aggravated by ω-3 PUFAs deficiency and alleviated by ω-3 PUFAs supplementation. This study discloses the novel findings that ω-3 PUFAs deficiency will exacerbate the metabolic disturbances in stressed rats. Furthermore, supplementation of ω-3 PUFAs on individuals with a high risk of depression might be an effective way to prevent metabolic disorders accompanied by depression with the involvement of INSIG/SREBP pathway.
Collapse
Affiliation(s)
- Mimi Tang
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China.
| | | | | | | | | | | |
Collapse
|
8
|
Hosomi R, Fukunaga K, Nagao T, Tanizaki T, Miyauchi K, Yoshida M, Kanda S, Nishiyama T, Takahashi K. Effect of Dietary Partial Hydrolysate of Phospholipids, Rich in Docosahexaenoic Acid-Bound Lysophospholipids, on Lipid and Fatty Acid Composition in Rat Serum and Liver. J Food Sci 2019; 84:183-191. [DOI: 10.1111/1750-3841.14416] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Revised: 11/07/2018] [Accepted: 11/14/2018] [Indexed: 11/28/2022]
Affiliation(s)
- Ryota Hosomi
- Faculty of Chemistry, Materials, and Bioengineering; Kansai Univ.; 3-3-35, Yamate-cho Suita Osaka 564-8680 Japan
| | - Kenji Fukunaga
- Faculty of Chemistry, Materials, and Bioengineering; Kansai Univ.; 3-3-35, Yamate-cho Suita Osaka 564-8680 Japan
| | - Toshihiro Nagao
- Osaka Research Inst. of Industrial Science and Technology; Morinomiya Center; 1-6-50, Morinomiya Joto-ku Osaka 536-8553 Japan
| | - Toshifumi Tanizaki
- Faculty of Chemistry, Materials, and Bioengineering; Kansai Univ.; 3-3-35, Yamate-cho Suita Osaka 564-8680 Japan
| | - Kazumasa Miyauchi
- Faculty of Chemistry, Materials, and Bioengineering; Kansai Univ.; 3-3-35, Yamate-cho Suita Osaka 564-8680 Japan
| | - Munehiro Yoshida
- Faculty of Chemistry, Materials, and Bioengineering; Kansai Univ.; 3-3-35, Yamate-cho Suita Osaka 564-8680 Japan
| | - Seiji Kanda
- Dept. of Public Health; Kansai Medical Univ.; 2-5-1, Shin-machi Hirakata Osaka 573-1010 Japan
| | - Toshimasa Nishiyama
- Dept. of Public Health; Kansai Medical Univ.; 2-5-1, Shin-machi Hirakata Osaka 573-1010 Japan
| | - Koretaro Takahashi
- Faculty of Engineering; Kitami Inst. of Technology; 165 Koen-cho Kitami Hokkaido 090-8507 Japan
| |
Collapse
|
9
|
Yu J, Ma Y, Sun J, Ran L, Li Y, Wang N, Yu T, Gao W, Jia W, Jiang R, Guo M, Bi Y, Wu Y. Microalgal Oil fromSchizochytriumsp. Prevents HFD-Induced Abdominal Fat Accumulation in Mice. J Am Coll Nutr 2017; 36:347-356. [DOI: 10.1080/07315724.2017.1302366] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Jinhui Yu
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
- Shandong Centre of Crop Germplasm Resources, Jinan, Shandong, China
| | - Yong Ma
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
| | - Jie Sun
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Liyuan Ran
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Youwei Li
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Ning Wang
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Tao Yu
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Wenting Gao
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
| | - Wenbin Jia
- Shandong Centre of Crop Germplasm Resources, Jinan, Shandong, China
| | - Rujiao Jiang
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Meihua Guo
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| | - Yuping Bi
- Biotechnology Research Center, Shang Dong Academy of Agricultural Sciences, Jinan, Shandong, China
| | - Yingjie Wu
- Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, Liaoning, China
- College of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, China
| |
Collapse
|
10
|
Komprda T, Rozíková V, Zamazalová N, Škultéty O, Vícenová M, Trčková M, Faldyna M. Effect of dietary fish oil on fatty acid deposition and expression of cholesterol homeostasis controlling genes in the liver and plasma lipid profile: comparison of two animal models. J Anim Physiol Anim Nutr (Berl) 2016; 101:1093-1102. [DOI: 10.1111/jpn.12581] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2016] [Accepted: 07/14/2016] [Indexed: 12/27/2022]
Affiliation(s)
- T. Komprda
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - V. Rozíková
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - N. Zamazalová
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - O. Škultéty
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - M. Vícenová
- Veterinary Research Institute; Brno Czech Republic
| | - M. Trčková
- Veterinary Research Institute; Brno Czech Republic
| | - M. Faldyna
- Veterinary Research Institute; Brno Czech Republic
| |
Collapse
|
11
|
Komprda T, Sládek Z, Škultéty O, Křížková S, Rozíková V, Němcová B, Šustrová T, Valová M. Effect of dietarySchizochytriummicroalga oil on selected markers of low-grade inflammation in rats. J Anim Physiol Anim Nutr (Berl) 2016; 100:1169-1178. [DOI: 10.1111/jpn.12434] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2015] [Accepted: 10/08/2015] [Indexed: 12/13/2022]
Affiliation(s)
- T. Komprda
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - Z. Sládek
- Department of Animal Morphology, Physiology and Genetics; Mendel University in Brno; Brno Czech Republic
| | - O. Škultéty
- Department of Animal Morphology, Physiology and Genetics; Mendel University in Brno; Brno Czech Republic
| | - S. Křížková
- Department of Chemistry and Biochemistry; Mendel University in Brno; Brno Czech Republic
| | - V. Rozíková
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - B. Němcová
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| | - T. Šustrová
- Department of Animal Morphology, Physiology and Genetics; Mendel University in Brno; Brno Czech Republic
| | - M. Valová
- Department of Food Technology; Mendel University in Brno; Brno Czech Republic
| |
Collapse
|